single

Cadila Healthcare announced that Zydus Cadila has received the tentative approval from the USFDA to market Tofacitinib tablets (US RLD - Xeljanz Tablets), 5 mg. Tofacitinib is used alone or with other medications (such as methotrexate) to treat moderate to severe forms of rheumatoid arthritis. It helps to decrease pain, tenderness and swelling in the joints. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad. The group now has 260 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-2004. The announcement was made on Saturday, 6 April 2019.

Torrent Pharmaceuticals announced that the audit at Dahej Plant was carried out by US Food and Drug Administration (USFDA) in March 2019. The company has received certain observations which are procedural in nature and the company is confident of addressing them satisfactorily. The announcement was made on Saturday, 6 April 2019.

NIIT Technologies announced on Saturday, 6 April 2019, that funds affiliated with Baring Private Equity Asia (BPEA), have signed definitive agreements to purchase approximately 1.88 crore NIIT Technologies shares (approximately 30% shareholding on a fully diluted basis in NIIT Technologies) from NIIT and other promoter entities at a price of Rs 1394 per share. The aggregate consideration for purchase of shares from promoter entities is estimated to be approximately Rs 2627 crore.

BPEA will make an open offer to the public shareholders of NIIT Technologies to purchase up to 26% additional shareholding at a price of Rs 1394 per share. The aggregate consideration for purchase of shares from promoter entities and the open offer is estimated to be up to approximately Rs 4890 crore based on ownership of approximately 56% stake.

In a separate announcement on Saturday, 6 April 2019, NIIT Technologies announced that it has signed a definitive agreement with WHISHWORKS IT Consulting, an IT services and consulting company specializing in MuleSoft and Big Data technologies, to acquire a 53% stake initially, with the remaining equity to be acquired over the next two years through pay-outs linked to financial performance. The transaction closure is subject to fulfillment of certain government/regulatory approvals.

Housing finance major HDFC announced after market hours on Friday, 5 April 2019, that during the quarter ended 31 March 2019, it assigned loans amounting to Rs 2,418 crore compared to nil in the corresponding quarter of the previous year. Income from dividend for the quarter ended 31 March 2019 was Rs 537 crore compared to Rs 332 crore in the corresponding quarter of the previous year. During the quarter ended 31 March 2019, the profit on sale of investments in subsidiary/associate companies was 314 crore compared to Rs 272 crore in corresponding quarter of the previous year.

HDFC Bank announced after market hours on Friday, 5 April 2019, that its advances aggregated to approximately Rs 8,19,500 crore as of 31 March 2019 as compared toRs 6,58,300 crore as of 31 March 2018 and Rs 7,81,000 crore as of 31 December 2018.

The bank's deposits aggregated to approximately Rs 9,23,000 crore as of 31 March 2019 as compared to Rs 7,88,800 crore as of 31 March 2018 and Rs 8,52,500 crore as of 31 December 2018. The bank's CASA ratio stood at around 42% as compared to 43.5% as of 31 March 2018 and 40.7% as of 31 December 2018. During the quarter ended 31 March 2019, the bank purchased loans aggregating Rs 1,924 crore through the direct assignment route under the home loan arrangement with Housing Development Finance Corporation.

Infosys announced after market hours on Friday, 5 April 2019, that it has strengthened its capabilities and presence in the turbomachinery and propulsion space with the opening of a new Infosys office in Baden, Switzerland. This office is part of Infosys' overall growth strategy of helping clients navigate their digital transformation journeys and will play an integral role in providing clients in the energy and aviation industries, the latest innovations in the fossil and renewable energy markets and aerospace.

TAGS

0 thoughts on “Cadila Healthcare in focus after tentative USFDA approval for Tofacitinib tabs”

Post Comment



  MCX Commodity Tips

MCX Commodity Tips is very much favorable to all and can be traded at any time in the market to whoever can trade after their job working hours as MCX market starts at 10:00am to 11:30pm mostly can be done with little investment and our calls reaching more accuracy. MCX Commodity Tips is also called as SureShot Commodity Tips as we maintain above 80% accuracy.


View My Stats